⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

CDTX News

Cidara Therapeutics, Inc.

Cidara Therapeutics Announces First Participants Dosed in Phase 3 ANCHOR Trial Evaluating CD388 for the Prevention of Seasonal Influenza in High-Risk Populations